Published in

Taylor and Francis Group, Expert Opinion on Drug Safety, 6(22), p. 493-500, 2023

DOI: 10.1080/14740338.2023.2181334

Links

Tools

Export citation

Search in Google Scholar

Safety and effectiveness of rivaroxaban for prevention of stroke in patients with nonvalvular atrial fibrillation: analysis of routine clinical data from four countries

Journal article published in 2023 by Luis Alberto García Rodríguez ORCID, Ana Ruigómez ORCID, Tania Schink ORCID, Annemarie Voss ORCID, Elisabeth Smits ORCID, Karin M. A. Swart ORCID, Yanina Balabanova ORCID, Kiliana Suzart-Woischnik ORCID, Gunnar Brobert ORCID, Ron M. C. Herings ORCID
Distributing this paper is prohibited by the publisher
Distributing this paper is prohibited by the publisher

Full text: Unavailable

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO